NCT00228163 Long Term Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses Status COMPLETED Phase PHASE2
NCT00228150 Study of the Effect of SR57667B on the Progression of Symptoms in Patients With Parkinson's Disease Status COMPLETED Phase PHASE2
NCT00227617 Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors Status TERMINATED Phase PHASE2/PHASE3
NCT00225667 Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers Status UNKNOWN Phase PHASE3
NCT00225420 Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00223938 Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients. Status TERMINATED Phase PHASE4
NCT00223665 Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer Status COMPLETED Phase PHASE2
NCT00222573 Efficacy and Safety of Adding Clopidogrel to Aspirin or Use of Metoprolol in Myocardial Infarction Status COMPLETED Phase PHASE4
NCT00222469 Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00220649 Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas Status COMPLETED Phase PHASE1
NCT00220272 Study of the Effect of SR57667B on 18F-Dopa PET Imaging in Patients With Parkinson's Disease Status COMPLETED Phase PHASE2
NCT00216138 Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & Neck Status TERMINATED Phase PHASE2
NCT00216125 Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT00216112 Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00216073 Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer Status TERMINATED Phase PHASE2
NCT00216060 Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy Status TERMINATED Phase PHASE3
NCT00216021 Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00215748 Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel Status TERMINATED Phase PHASE2
NCT00215709 Bi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate Cancer Status COMPLETED Phase PHASE1